Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bausch Health Companies (BHC)
NYSE:BHC
RESEARCH TOOLSreports
Holding BHC?
Track your performance easily
BHC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.96 - $11.46
Previous Close$7.48
Volume376.69K
Average Volume (3M)1.63M
Market Cap
$2.88B
Enterprise Value$24.46B
Total Cash (Recent Filing)$719.00M
Total Debt (Recent Filing)$21.51B
Price to Earnings (P/E)―
Beta1.30
Next Earnings
Feb 19, 2025EPS Estimate
$1.09Last Dividend Ex-Date
Nov 10, 2010Dividend YieldN/A
Share Statistics
EPS (TTM)-0.48
Shares Outstanding367,803,401
10 Day Avg. Volume1,557,648
30 Day Avg. Volume1,626,420
Standard Deviation0.16
R-Squared0.05
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)-2.35
Price to Sales (P/S)0.29
Price to Cash Flow (P/CF)1.70
P/FCF Ratio0.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.56
Enterprise Value/Gross Profit3.95
Enterprise Value/Ebitda9.81
Forecast
1Y Price Target
$8.25Price Target Upside5.10% Upside
Rating ConsensusHold
Number of Analyst Covering5
Bausch Health Companies News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceBHC total revenue was significantly above estimates, showcasing strong performance.
Market DemandBausch & Lomb sales exceeded projections, indicating robust demand in this segment.
Strategic InitiativesThe eventual separation of BLCO would unlock value for BHC shares.
Bears Say
Debt And SolvencyWith ~$9.4B in debt coming due in the 2027/2028 timeframe, solvency remains a major concern.
EarningsEarnings per share missed expectations, highlighting a potential area of concern.
Management And StrategyCompany split process remains opaque, with management providing no new updates on timeline or path.
---
Ownership Overview
19.01% Insiders
4.07% Mutual Funds
45.18% Other Institutional Investors
27.30% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BHC FAQ
What was Bausch Health Companies’s price range in the past 12 months?
Bausch Health Companies lowest stock price was $3.96 and its highest was $11.46 in the past 12 months.
What is Bausch Health Companies’s market cap?
Currently, no data Available
When is Bausch Health Companies’s upcoming earnings report date?
Bausch Health Companies’s upcoming earnings report date is Feb 19, 2025 which is in 57 days.
How were Bausch Health Companies’s earnings last quarter?
Bausch Health Companies released its earnings results on Oct 30, 2024. The company reported $1.107 earnings per share for the quarter, beating the consensus estimate of $0.985 by $0.122.
Is Bausch Health Companies overvalued?
According to Wall Street analysts Bausch Health Companies’s price is currently Undervalued.
Does Bausch Health Companies pay dividends?
Bausch Health Companies pays a Quarterly dividend of $1 which represents an annual dividend yield of N/A. See more information on Bausch Health Companies dividends here
What is Bausch Health Companies’s EPS estimate?
Bausch Health Companies’s EPS estimate is $1.09.
How many shares outstanding does Bausch Health Companies have?
Bausch Health Companies has 367,803,400 shares outstanding.
What happened to Bausch Health Companies’s price movement after its last earnings report?
Bausch Health Companies reported an EPS of $1.107 in its last earnings report, beating expectations of $0.985. Following the earnings report the stock price went up 12.607%.
Which hedge fund is a major shareholder of Bausch Health Companies?
Among the largest hedge funds holding Bausch Health Companies’s share is Carl Icahn C. It holds Bausch Health Companies’s shares valued at 283M.
---
Company Description
Bausch Health Companies
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets.
---
BHC Company Deck
---
BHC Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a strong quarter for Bausch Health with significant revenue and EBITDA growth, leading to an increase in full-year guidance. The company showcased robust performance in international and Solta segments, along with continued growth opportunities for XIFAXAN. However, challenges remain due to ongoing litigation and increased operating expenses.Read More>---
BHC Revenue Breakdown
44.64% Pharmaceuticals
22.80% Devices
20.52% OTC
10.96% Branded and Other Generics
1.07% Other
---
BHC Stock 12 Month Forecast
Average Price Target
$8.25
▲(5.10% Upside)
Technical Analysis
Teva Pharmaceutical
―
Dr Reddy's Laboratories
―
Amphastar Pharmaceuticals
―
Perrigo Company
―
Best Analysts Covering BHC
1 Year
1 Year Success Rate
10/26 ratings generated profit
1 Year Average Return
-12.65%
reiterated a sell rating 2 months ago
Copying David Amsellem's trades and holding each position for 1 Year would result in 38.46% of your transactions generating a profit, with an average return of -12.65% per trade.
---